Health Care Industry News

Raptor Pharmaceutical's genetic disorder drug meets midstage study goals

Sun (Baltimore), The | 9 minutes ago

Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)


Latest Health Care Industry NewsMore >


Spray can prevent premature ejaculation: study

Yahoo! | 16 minutes ago

Seattle Genetics gets $12 million in Astellas deal

San Francisco Chronicle | 17 minutes ago

Bristol-Myers extends partnership with Asterand

San Francisco Chronicle | 18 minutes ago

Wire Business News

Sacramento Bee (Calif.), The | 18 minutes ago


Readers ChoiceMore >


Vaccines become more attractive to drug developers

BIO SmartBrief | Nov 19, 2009

Qiagen is prepared for more acquisitions, CFO says

BIO SmartBrief | Nov 18, 2009

Onyx finalizes acquisition of Proteolix

BIO SmartBrief | Nov 17, 2009

Drug executives list pros, cons of health reform

BIO SmartBrief | Nov 19, 2009

GINA law to take effect this month

BIO SmartBrief | Nov 16, 2009


BIO News More >


Grant-funding opportunities

BIO SmartBrief | Nov 23, 2009

Looking for new strategies for managing your company's cash flow during this economic lull?

BIO SmartBrief | Nov 20, 2009

Feeling the pinch in today's market hurts

BIO SmartBrief | Nov 19, 2009

Registration now open for 2010 BIO Asia Partnering Conference

BIO SmartBrief | Nov 18, 2009

Honolulu says "Aloha" to industrial biotechnology

BIO SmartBrief | Oct 30, 2009


Latest Health Care Industry Press ReleasesMore >


SHIRE PLC - Blocklisting - Interim Review

PRNewswire | 1 hour 44 minutes ago

Oncolytics Biotech(R) Inc. Closes US$12.75 Million Unit Offering

PRNewswire | 2 hours 15 minutes ago

Seattle Genetics and Agensys, an Affiliate of Astellas, Expand Antibody-Drug Conjugate Collaboration

Business Wire | 2 hours 15 minutes ago

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis

PRNewswire | 3 hours 43 minutes ago

Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders

PRNewswire | 3 hours 43 minutes ago

Pearl Therapeutics Appoints Howie Rosen to Board of Directors

PRNewswire | 3 hours 43 minutes ago



Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Latest Blog Postsview more


Companies in the news